重组人血清白蛋白：是真正的治疗替代品还是仅仅是血清水平提升剂？ - Suppr | 超能文献

相似文献

1

Recombinant human serum albumin: a true therapeutic substitute or merely a serum level elevator?重组人血清白蛋白：是真正的治疗替代品还是仅仅是血清水平提升剂？

Hepatol Int. 2025 Sep 19. doi: 10.1007/s12072-025-10902-7.

2

CFD-based aerodynamic optimization of the fairing for a high-speed elevator.基于计算流体动力学的高速电梯整流罩气动优化

Sci Rep. 2025 Jul 1;15(1):22243. doi: 10.1038/s41598-025-06139-x.

3

Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial.大米来源的重组人血清白蛋白替代失代偿期肝硬化患者的人血浆：一项随机、双盲、阳性对照和非劣效性试验。

Gut. 2025 Aug 7;74(9):1476-1485. doi: 10.1136/gutjnl-2025-335577.

4

Postmortem CT and autopsy findings in an elevator-related death: a case report.一例电梯相关死亡的尸检CT及尸检结果：病例报告

Forensic Sci Med Pathol. 2024 Sep 20. doi: 10.1007/s12024-024-00896-3.

5

Multimodal Fusion-Based Self-Calibration Method for Elevator Weighing Towards Intelligent Premature Warning.基于多模态融合的电梯称重智能提前预警自校准方法

Sensors (Basel). 2025 Sep 5;25(17):5550. doi: 10.3390/s25175550.

6

Novel role of serum albumin imidase activity in the formation of BI 761036 (M232), a major metabolite of iclepertin.血清白蛋白亚胺酶活性在艾考替哌汀主要代谢物BI 761036（M232）形成中的新作用。

Drug Metab Dispos. 2025 May 8;53(7):100093. doi: 10.1016/j.dmd.2025.100093.

7

Double elevator palsy.双提肌麻痹

Arch Ophthalmol. 1979 May;97(5):901-3. doi: 10.1001/archopht.1979.01020010459013.

8

Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute.在全氟化合物血液代用品存在的情况下华法林与人血清白蛋白的结合。

Arch Int Pharmacodyn Ther. 1985 Sep;277(1):4-14.

9

A randomized, phase Ib trial of recombinant human serum albumin in cirrhotic patients with ascites.重组人血清白蛋白用于肝硬化腹水患者的随机1b期试验。

Hepatol Int. 2025 Jul 23. doi: 10.1007/s12072-025-10871-x.

10

A prospective comparison of Synthetic Serum Substitute and human serum albumin in culture for in vitro fertilization-embryo transfer.合成血清替代品与人类血清白蛋白在体外受精-胚胎移植培养中的前瞻性比较。

Fertil Steril. 1995 Nov;64(5):1036-8. doi: 10.1016/s0015-0282(16)57926-6.

本文引用的文献

1

Comment on "CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study".关于“基于CT的肿瘤内及瘤周放射组学预测高危肝细胞癌病例肝动脉灌注化疗联合乐伐替尼及PD-1治疗反应的多中心研究”的评论

Hepatol Int. 2025 Sep 15. doi: 10.1007/s12072-025-10912-5.

2

Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies.中国慢性肝衰竭协作组（China-CLIF）框架在慢加急性肝衰竭中的应用：一项涵盖所有病因的多队列研究

Gut. 2025 Aug 7. doi: 10.1136/gutjnl-2025-335651.

3